Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed

por Vijayvergia, Namrata, Denlinger, Crystal S.
Publicado 2015

A Case of Radiation Recall Myositis and Neuropathy in Locally Advanced Rectal Cancer

por Lee, Charles T., Denlinger, Crystal S., Meyer, Joshua E.
Publicado 2021

Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas

por Malik, Faizan, Ali, Naveed, Durrani, Jibran, Mustafa, Syed Imran, Denlinger, Crystal
Publicado 2017

Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors

por Denlinger, Crystal S., Keedy, Vicki L., Moyo, Victor, MacBeath, Gavin, Shapiro, Geoffrey I.
Publicado 2021

Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy

por Jain, Rishi, Shaikh, Talha, Yee, Jia-Llon, Au, Cherry, Denlinger, Crystal S., Handorf, Elizabeth, Meyer, Joshua E., Dotan, Efrat
Publicado 2020

Pancreas Cancer‐Associated Weight Loss

por Hendifar, Andrew E., Petzel, Maria Q.B., Zimmers, Teresa A., Denlinger, Crystal S., Matrisian, Lynn M., Picozzi, Vincent J., Rahib, Lola
Publicado 2018

Lack of pharmacokinetic drug–drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors

por Chow, Laura Q. M., Smith, David C., Tan, Antoinette R., Denlinger, Crystal S., Wang, Ding, Shepard, Dale R., Chaudhary, Archana, Lin, Yong, Gao, Ling
Publicado 2016

Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors

por McGillivray, Erin, Jain, Rishi, Ramamurthy, Chethan, Sheng, Jennifer Y., Granina, Evgenia, Yu, Daohai, Lu, Xiaoning, Abbas, Abbas E., Dotan, Efrat, Meyer, Joshua E., Fang, Carolyn Y., Denlinger, Crystal S.
Publicado 2023

Leveraging patient‐reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience

por Gupta, Arjun, Khalid, Omar, Moravek, Cassadie, Lamkin, Anica, Matrisian, Lynn M., Doss, Sudheer, Denlinger, Crystal S., Coveler, Andrew L., Weekes, Colin D., Roeland, Eric J., Hendifar, Andrew E., Nipp, Ryan D.
Publicado 2021

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials

por Vijayvergia, Namrata, Dasari, Arvind, Deng, Mengying, Litwin, Samuel, Al-Toubah, Taymeyah, Alpaugh, R. Katherine, Dotan, Efrat, Hall, Michael J., Ross, Nicole M., Runyen, Melissa M., Denlinger, Crystal S., Halperin, Daniel M., Cohen, Steven J., Engstrom, Paul F., Strosberg, Jonathan R.
Publicado 2020

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors

por Zibelman, Matthew, MacFarlane, Alexander W., Costello, Kimberly, McGowan, Thomas, O’Neill, John, Kokate, Rutika, Borghaei, Hossein, Denlinger, Crystal S., Dotan, Efrat, Geynisman, Daniel M., Jain, Angela, Martin, Lainie, Obeid, Elias, Devarajan, Karthik, Ruth, Karen, Alpaugh, R. Katherine, Dulaimi, Essel Al-Saleem, Cukierman, Edna, Einarson, Margret, Campbell, Kerry S., Plimack, Elizabeth R.
Publicado 2023

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

por Brown, Justin C, Zhang, Sui, Ou, Fang-Shu, Venook, Alan P, Niedzwiecki, Donna, Lenz, Heinz-Josef, Innocenti, Federico, O’Neil, Bert H, Shaw, James E, Polite, Blase N, Denlinger, Crystal S, Atkins, James N, Goldberg, Richard M, Ng, Kimmie, Mayer, Robert J, Blanke, Charles D, O’Reilly, Eileen M, Fuchs, Charles S, Meyerhardt, Jeffrey A
Publicado 2019